Cygnus Capital Advisors LLC Has $151,000 Position in Cypherpunk Technologies $CYPH

Cygnus Capital Advisors LLC increased its holdings in shares of Cypherpunk Technologies (NASDAQ:CYPH) by 2,044.6% in the 2nd quarter, Holdings Channel.com reports. The firm owned 246,460 shares of the company’s stock after acquiring an additional 234,968 shares during the quarter. Cygnus Capital Advisors LLC’s holdings in Cypherpunk Technologies were worth $151,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Millennium Management LLC bought a new stake in Cypherpunk Technologies during the 4th quarter valued at approximately $37,000. LPL Financial LLC bought a new position in Cypherpunk Technologies in the 4th quarter worth approximately $38,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Cypherpunk Technologies during the fourth quarter worth approximately $44,000. Sequoia Financial Advisors LLC acquired a new position in shares of Cypherpunk Technologies during the fourth quarter worth approximately $56,000. Finally, HighTower Advisors LLC bought a new stake in shares of Cypherpunk Technologies in the fourth quarter valued at approximately $59,000. Institutional investors own 30.46% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $1.60 price objective on shares of Cypherpunk Technologies in a research note on Thursday, August 27th. Wall Street Zen upgraded shares of Cypherpunk Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, July 4th. Finally, Weiss Ratings upgraded shares of Cypherpunk Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 17th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $1.60.

Insider Buying and Selling

In related news, Director Thomas Dietz sold 20,000 shares of the firm’s stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $1.72, for a total value of $34,400.00. Following the completion of the transaction, the director directly owned 132,500 shares of the company’s stock, valued at $227,900. This trade represents a 13.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 3.50% of the stock is currently owned by company insiders.

Cypherpunk Technologies Price Performance

Cypherpunk Technologies stock opened at $2.42 on Tuesday. The business has a 50 day moving average price of $0.98 and a two-hundred day moving average price of $0.88. Cypherpunk Technologies has a 12 month low of $0.27 and a 12 month high of $3.70. The stock has a market cap of $260.78 million, a price-to-earnings ratio of 4.32 and a beta of 0.33.

Cypherpunk Technologies (NASDAQ:CYPH) last announced its quarterly earnings data on Wednesday, August 12th. The company reported $0.18 earnings per share for the quarter.

Cypherpunk Technologies Profile

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.